WFDC2 and endometrial cancer: HE4 overexpression was demonstrated to promote cancer cell proliferation, migration, invasion, and metastasis in vitro and to enhance tumor growth, metastasis rate, and platinum-chemoresistance in vivo, both in ovarian and endometrial cancer cell lines (26–29).